(Q33362066)

26 July 2017

1 reference

title

Paclitaxel: as adjuvant or neoadjuvant therapy in early breast cancer (English)

1 reference

26 July 2017

1 reference

2

Greg L Plosker

1 reference

26 July 2017

Dene Simpson

1

1 reference

26 July 2017

publication date

1 January 2004

1 reference

26 July 2017

1 reference

26 July 2017

volume

64

1 reference

26 July 2017

issue

16

1 reference

26 July 2017

page(s)

1839-1847

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200464160-00008

26 July 2017

exact match

0 references

cites work

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

1 reference

12 December 2020

The current state of adjuvant therapy for breast cancer: focus on paclitaxel.

1 reference

12 December 2020

Paclitaxel. An update of its use in the treatment of metastatic breast cancer and ovarian and other gynaecological cancers

1 reference

12 December 2020

Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer.

1 reference

12 December 2020

Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer.

1 reference

12 December 2020

Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer

1 reference

12 December 2020

Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial.

1 reference

12 December 2020

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

1 reference

12 December 2020

Dose-dense paclitaxel-containing adjuvant therapy for breast cancer.

1 reference

12 December 2020

10.2165/00003495-200464160-00008

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

1045997812

0 references

1 reference